Jump Financial’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
Other funds holding FOLD
VCM
PCM
VPM
GCL
Jump Financial's FOLD Position: Q1 2026 in Review
Jump Financial sold out of Amicus Therapeutics (FOLD) in Q1 2026, closing a stake of 609,941 shares — an estimated $8.69M sold.
Jump Financial first reported a position in FOLD in Q1 2021 and held it in 17 quarters. The position peaked at $8.69M in Q4 2025. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.
- Jump Financial reported no remaining Amicus Therapeutics position as of Q1 2026 after selling out during the quarter.
- Jump Financial sold 609,941 Amicus Therapeutics shares in Q1 2026, an estimated $8.69M.
- Jump Financial first reported a position in Amicus Therapeutics in Q1 2021 and held it in 17 quarters.
- Jump Financial's Amicus Therapeutics position peaked at $8.69M in Q4 2025.
- 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.
Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.